Large swathes of the medical community now see obesity as a biological disease rather than a personal failing
Compounded products do not pass through that same approval process
By modifying the peptide to bind strongly to albumin (an abundant blood protein) and resist enzymatic degradation, scientists created a GLP-1 agonist that required injection only once weekly
It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
8 Keys to Smarter GLP-1 Therapy DOSING THAT FITS YOU MyLevel Precision Titration Using MyLevel, we adjust dosing to keep your active medication level within your personal target range, supporting steady fat loss of 12 lbs per week while minimizing side effects